Cargando…

Correction: Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488309/ https://www.ncbi.nlm.nih.gov/pubmed/26121339 http://dx.doi.org/10.1371/journal.pone.0132230

Ejemplares similares

Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs
por: Uitdehaag, Joost C. M., et al.
Publicado: (2015)

Correction: FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
por: Byron, Sara A., et al.
Publicado: (2012)

Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer
por: Entrialgo‑Cadierno, Rodrigo, et al.
Publicado: (2023)

Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
por: Ruan, Hang, et al.
Publicado: (2022)

Correction: The UVSSA complex alleviates MYC-driven transcription stress
por: Sato, Mai, et al.
Publicado: (2023)

Correction to: m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
por: Liu, Li, et al.
Publicado: (2020)

Correction to: Screening and computational analysis of colorectal associated non-synonymous polymorphism in CTNNB1 gene in Pakistani population
por: Razak, S., et al.
Publicado: (2020)

Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
por: Costa-Cabral, Sara, et al.
Publicado: (2018)

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
por: Costa-Cabral, Sara, et al.
Publicado: (2016)

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
por: Costa-Cabral, Sara, et al.
Publicado: (2017)

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
por: Xu, Ke, et al.
Publicado: (2020)

Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2023)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
por: Best, Sarah A., et al.
Publicado: (2020)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
por: Boshuizen, Julia, et al.
Publicado: (2023)

Correction: Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2018)

Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget
por: Qiu, Ya-Qi, et al.
Publicado: (2019)

CTNNB1 in neurodevelopmental disorders
por: Zhuang, Wenting, et al.
Publicado: (2023)

Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state
por: Poli, Vittoria, et al.
Publicado: (2018)

Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2016)

Selective targeting of KRAS-driven lung tumorigenesis via unresolved ER stress
por: Shimomura, Iwao, et al.
Publicado: (2021)

Correction: SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer
por: Suresh, Shruthy, et al.
Publicado: (2018)

Correction: Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells
por: Fowler, Trent, et al.
Publicado: (2015)

Beyond Kras: MYC Rules in Pancreatic Cancer
por: Korc, Murray
Publicado: (2018)

Correction: Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
por: Wu, Chi-Hwa, et al.
Publicado: (2013)

Correction to: MAGE‑C2/CT10 promotes growth and metastasis through upregulating c‑Myc expression in prostate cancer
por: Qiu, Jun, et al.
Publicado: (2020)

The Role of CTNNB1 in Endometrial Cancer
por: Ledinek, Živa, et al.
Publicado: (2022)

Correction to: Emerging roles of Myc in stem cell biology and novel tumor therapies
por: Yoshida, Go J.
Publicado: (2018)

Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2021)

Correction: Voting-Based Cancer Module Identification by Combining Topological and Data-Driven Properties
por: Azad, A. K. M., et al.
Publicado: (2014)

Correction: Voting-Based Cancer Module Identification by Combining Topological and Data-Driven Properties
Publicado: (2014)

Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
por: Bartolacci, Caterina, et al.
Publicado: (2022)

Author Correction: Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse
por: Malik, Bhawna, et al.
Publicado: (2019)

Correction to: PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
por: Zhao, Bin, et al.
Publicado: (2021)

Correction: Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice
Publicado: (2018)

Correction: Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

Correction: The [PSI(+)] Prion Exists as a Dynamic Cloud of Variants
Publicado: (2017)

Publisher Correction: Multiple similarly effective solutions exist for biomedical feature selection and classification problems
por: Liu, Jiamei, et al.
Publicado: (2018)

Author Correction: Multiple similarly effective solutions exist for biomedical feature selection and classification problems
por: Liu, Jiamei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bkng0sts81en6tju2fm0opq0ra